Novel Mutation of ZAP-70-related Combined Immunodeficiency: First Case from the National Iranian Registry and Review of the Literature

References

• Abolhassani H, Wang N, Aghamohammadi A, et al. (2014). A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol, 134(6), 1375–1380.
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Mohammadinejad P, Abolhassani H, et al. (2014). Primary immunodeficiency disorders in Iran: Update and new insights from the third report of the national registry. J Clin Immunol, 34(4), 478–490.
   PubMed Web of Science ®Google Scholar
• Akar HH, Patiroglu T, Akyildiz BN, et al. (2015). Silent brain infarcts in two patients with zeta chain-associated protein 70 kDa (ZAP70) deficiency. Clin Immunol, 158(1), 88–91.
   PubMed Web of Science ®Google Scholar
• Arpaia E, Shahar M, Dadi H, et al. (1994). Defective T cell receptor signaling and CD8+ thymic selection in humans lacking zap-70 kinase. Cell, 76(5), 947–958.
   PubMed Web of Science ®Google Scholar
• Bily-Prygowa Z. (1975). [Atypical development of roots of upper incisors after mechanical injury]. Czas Stomatol, 28(8), 797–802.
   PubMedGoogle Scholar
• Bykowsky MJ, Haire RN, Ohta Y, et al. (1996). Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet, 58(3), 477–483.
   PubMed Web of Science ®Google Scholar
• Chan AC, Kadlecek TA, Elder ME, et al. (1994). ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science, 264(5165), 1599–1601.
   PubMed Web of Science ®Google Scholar
• Chan AY, Punwani D, Kadlecek TA, et al. (2016). A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70. J Exp Med, 213(2), 155–165.
   PubMed Web of Science ®Google Scholar
• CM R. ZAP-70 deficiency. UpToDate, 2014.
   Google Scholar
• Elder ME. (1996). Severe combined immunodeficiency due to a defect in the tyrosine kinase ZAP-70. Pediatr Res, 39(5), 743–748.
   PubMed Web of Science ®Google Scholar
• Elder ME, Hope TJ, Parslow TG, et al. (1995). Severe combined immunodeficiency with absence of peripheral blood CD8+ T cells due to ZAP-70 deficiency. Cell Immunol, 165(1), 110–117.
   PubMed Web of Science ®Google Scholar
• Elder ME, Lin D, Clever J, et al. (1994). Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science, 264(5165), 1596–1599.
   PubMed Web of Science ®Google Scholar
• Elder ME, Skoda-Smith S, Kadlecek TA, et al. (2001). Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J Immunol, 166(1), 656–661.
   PubMed Web of Science ®Google Scholar
• Esenboga S, Ayvaz DC, Cetinkaya PG, et al. (2016). An infant with ZAP-70 deficiency with disseminated mycobacterial disease. J Clin Immunol, 36(2), 103–106.
   PubMed Web of Science ®Google Scholar
• Fagioli F, Biasin E, Berger M, et al. (2003). Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome. Bone Marrow Transplant, 31(2), 133–136.
   PubMed Web of Science ®Google Scholar
• Gelfand EW, Weinberg K, Mazer BD, et al. (1995). Absence of ZAP-70 prevents signaling through the antigen receptor on peripheral blood T cells but not on thymocytes. J Exp Med, 182(4), 1057–1065.
   PubMed Web of Science ®Google Scholar
• Hauck F, Blumenthal B, Fuchs S, et al. (2015). SYK expression endows human ZAP70-deficient CD8 T cells with residual TCR signaling. Clin Immunol, 161(2), 103–109.
   PubMed Web of Science ®Google Scholar
• Hivroz C, Fischer A. (1994). Immunodeficiency diseases. Multiple roles for ZAP-70. Curr Biol, 4(8), 731–733.
   PubMed Web of Science ®Google Scholar
• Honig M, Schuetz C, Schwarz K, et al. (2012). Immunological reconstitution in a patient with ZAP-70 deficiency following transfusion of blood lymphocytes from a previously transplanted sibling without conditioning. Bone Marrow Transplant, 47(2), 305–307.
   PubMed Web of Science ®Google Scholar
• Huber RG, Fan H, Bond PJ. (2015). The structural basis for activation and inhibition of ZAP-70 kinase domain. PLoS Comput Biol, 11(10), e1004560. doi:10.1371/journal.pcbi.1004560
   Google Scholar
• Karaca E, Karakoc-Aydiner E, Bayrak OF, et al. (2013). Identification of a novel mutation in ZAP70 and prenatal diagnosis in a Turkish family with severe combined immunodeficiency disorder. Gene, 512(2), 189–193.
   PubMed Web of Science ®Google Scholar
• Katamura K, Tai G, Tachibana T, et al. (1999). Existence of activated and memory CD4+ T cells in peripheral blood and their skin infiltration in CD8 deficiency. Clin Exp Immunol, 115(1), 124–130.
   PubMed Web of Science ®Google Scholar
• Kaur M, Singh M, Silakari O. (2014) Insight into the therapeutic aspects of ‘Zeta-Chain Associated Protein Kinase 70 kDa’ inhibitors: A review. Cell Signal, 26(11), 2481–192.
   PubMed Web of Science ®Google Scholar
• Kim VH, Murguia L, Schechter T, et al. (2013). Emergency treatment for zeta chain-associated protein of 70 kDa (ZAP70) deficiency. J Allergy Clin Immunol, 131(4), 1233–1235.
   PubMed Web of Science ®Google Scholar
• Latif AH, Tabassomi F, Abolhassani H, Hammarstrom L. (2014). Molecular diagnosis of primary immunodeficiency diseases in a developing country: Iran as an example. Expert Rev Clin Immunol, 10(3), 385–396.
   PubMed Web of Science ®Google Scholar
• Liao Z, Zhou L, Wang C, et al. (2015). Characteristics of TCRzeta, ZAP-70, and FcvarepsilonRIgamma gene expression in patients with T- and NK/T-cell lymphoma. DNA Cell Biol, 34(3), 201–207.
   PubMed Web of Science ®Google Scholar
• Matsuda S, Suzuki-Fujimoto T, Minowa A, et al. (1999). Temperature-sensitive ZAP70 mutants degrading through a proteasome-independent pathway. Restoration of a kinase domain mutant by Cdc37. J Biol Chem, 274(49), 34515–34518.
   PubMed Web of Science ®Google Scholar
• Meinl E, Lengenfelder D, Blank N, et al. (2000). Differential requirement of ZAP-70 for CD2-mediated activation pathways of mature human T cells. J Immunol, 165(7), 3578–3583.
   PubMed Web of Science ®Google Scholar
• Modell V, Knaus M, Modell F, et al. (2014). Global overview of primary immunodeficiencies: A report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res, 60(1), 132–144.
   PubMed Web of Science ®Google Scholar
• Newell A, Dadi H, Goldberg R, et al. (2011). Diffuse large B-cell lymphoma as presenting feature of Zap-70 deficiency. J Allergy Clin Immunol, 127(2), 517–520.
   PubMed Web of Science ®Google Scholar
• Noraz N, Schwarz K, Steinberg M, et al. (2000). Alternative antigen receptor (TCR) signaling in T cells derived from ZAP-70-deficient patients expressing high levels of Syk. J Biol Chem, 275(21), 15832–15838.
   PubMed Web of Science ®Google Scholar
• Picard C, Dogniaux S, Chemin K, et al. (2009). Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity. Eur J Immunol, 39(7), 1966–1976.
   PubMed Web of Science ®Google Scholar
• Poliani PL, Fontana E, Roifman CM, Notarangelo LD. (2013). zeta Chain-associated protein of 70 kDa (ZAP70) deficiency in human subjects is associated with abnormalities of thymic stromal cells: Implications for T-cell tolerance. J Allergy Clin Immunol, 131(2), 597–600e1-2.
   PubMed Web of Science ®Google Scholar
• Rao N, Lupher ML Jr, Ota S, et al. (2000). The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J Immunol, 164(9), 4616–4626.
   PubMed Web of Science ®Google Scholar
• Roifman CM, Dadi H, Somech R, et al. (2010). Characterization of zeta-associated protein, 70 kd (ZAP70)-deficient human lymphocytes. J Allergy Clin Immunol, 126(6), 1226–1233e1.
   PubMed Web of Science ®Google Scholar
• Roifman CM, Hummel D, Martinez-Valdez H, et al. (1989). Depletion of CD8+ cells in human thymic medulla results in selective immune deficiency. J Exp Med, 170(6), 2177–2182.
   PubMed Web of Science ®Google Scholar
• Rosenberg SL, Larkin A. (1993). ZAP70-related severe combined immunodeficiency, in GeneReviews(R), R.A. Pagon, et al. (eds.). Seattle (WA).
   Google Scholar
• Schim van der Loeff I, Hsu LY, Saini M, et al. (2014). Zap70 is essential for long-term survival of naive CD8 T cells. J Immunol, 193(6), 2873–2880.
   PubMed Web of Science ®Google Scholar
• Toyabe S, Watanabe A, Harada W, et al. (2001). Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling. Immunology, 103(2), 164–171.
   PubMed Web of Science ®Google Scholar
• Turul T, Tezcan I, Artac H, et al. (2009). Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. Eur J Pediatr, 168(1), 87–93.
   PubMed Web of Science ®Google Scholar